Evidence map›Paper›PMID 29517484›Full record

ArticleeLife2018

Sumoylation promotes optimal APC/C Activation and Timely Anaphase.

Christine C Lee, Bing Li, Hongtao Yu, Michael J Matunis

Abstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. DeSUMOylating isopeptidase 1 participates in the faithful chromosome segregation and vincristine sensitivity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  4. Multifaceted roles of SUMO in DNA metabolism.Nucleus (Austin, Tex.) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christine C LeeDepartment of Biochemistry and Molecular Biology, Johns Hopkins University, Baltimore, United States.ORCID http://orcid.org/0000-0003-4540-1628
Bing LiDepartment of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, United States.
Hongtao YuDepartment of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, United States.ORCID http://orcid.org/0000-0002-8861-049X
Michael J MatunisDepartment of Biochemistry and Molecular Biology, Johns Hopkins University, Baltimore, United States.ORCID http://orcid.org/0000-0002-9350-6611

Funding

TRAINING IN AREAS FUNDAMENTAL TO CANCER RESEARCHT32CA009110 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATUNIS, MICHAEL J., WEERARATNA, ASHANI T · 1985 to 2025
$13.1M
Regulation and Function of SUMO Protein Modification -Equipment SupplementR01GM060980 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI MATUNIS, MICHAEL J. · 2000 to 2023
$7.1M
Howard Hughes Medical InstituteNCI NIH HHS T32 CA009110NIGMS NIH HHS R01 GM060980NIH HHS GM060980NIH HHS T32 CA009110
6 · The paper itself

Abstract

The Anaphase Promoting Complex/Cyclosome (APC/C) is a ubiquitin E3 ligase that functions as the gatekeeper to mitotic exit. APC/C activity is controlled by an interplay of multiple pathways during mitosis, including the spindle assembly checkpoint (SAC), that are not yet fully understood. Here, we show that sumoylation of the APC4 subunit of the APC/C peaks during mitosis and is critical for timely APC/C activation and anaphase onset. We have also identified a functionally important SUMO interacting motif in the cullin-homology domain of APC2 located near the APC4 sumoylation sites and APC/C catalytic core. Our findings provide evidence of an important regulatory role for SUMO modification and binding in affecting APC/C activation and mitotic exit.

Indexed as

AnaphaseAnaphase-Promoting Complex-CyclosomeApc4 Subunit, Anaphase-Promoting Complex-CyclosomeCatalytic DomainCytoskeletal ProteinsHeLa CellsHumansMitosisM Phase Cell Cycle CheckpointsPlasmidsProtein BindingProtein ConformationSpindle ApparatusSumoylationUbiquitinationUbiquitin-Protein LigasesANAPC4 protein, humanAnaphase-Promoting Complex-CyclosomeAPC2 protein, humanApc4 Subunit, Anaphase-Promoting Complex-CyclosomeCytoskeletal ProteinsUbiquitin-Protein LigasesAPC4APC/Ccell biologycell cycleE. colihumanmitosisSUMOubiquitin E3 ligase

Identifiers

PMID29517484
PMCPMC5884673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.